Drug name
Last update: Sep 202610E8.4/iMab
Developer(s)
Drug information
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Unknown
Unknown
Therapeutic area(s)
- HIV
- Pre-Exposure Prophylaxis (PrEP)
- Treatment
Administration route
Intramuscular, Intravenous, Route of administration is being determined in the clinical program
Associated long-acting platforms
Monoclonal antibodies and antibody drug conjugates
Use of drug
- To be determined
- Other/Variable/Unknown : To be determined
Dosage
Not provided
Not provided
Not provided
bispecific monoclonal antibody, potentially to be used alone or in combination with VRC07-523LS. It is tested for prevention (IV) as well as for treatment of HIV
Not provided
Associated compounds, formulations and regimens
Not provided
Associated technologies
Not provided
Additional information
Developer(s)
Columbia University
Drug structure
Scale-up and manufacturing prospects
Not provided
Not provided
Not provided
Not provided
Excipients & delivery device(s)
Not provided
Not provided
Not provided
Not provided
Safety, Efficacy and Evidence Summary
Not provided
Not provided
Not provided
Not provided
There are either no relevant patents or these were not yet submitted to LAPaL